Back to Search
Start Over
Patent Issued for Topical Formulations Having Enhanced Bioavailability (USPTO 10,588,859)
- Source :
- Obesity, Fitness & Wellness Week. April 4, 2020, 1179
- Publication Year :
- 2020
-
Abstract
- 2020 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Berg LLC (Framingham, Massachusetts, United States) has been issued patent number 10,588,859, [...]
- Subjects :
- Miglitol -- Intellectual property
Clemastine -- Intellectual property
Nalbuphine -- Intellectual property
Rifapentine -- Intellectual property
Dirithromycin -- Intellectual property
Paricalcitol
Valsartan
Halofantrine -- Intellectual property
Metronidazole -- Intellectual property
Povidone -- Intellectual property
Efavirenz -- Intellectual property
Oxaprozin -- Intellectual property
Fenofibrate -- Intellectual property
Physical fitness
Cilostazol -- Intellectual property
Tizanidine -- Intellectual property
Anticonvulsants -- Intellectual property
Telmisartan -- Intellectual property
Butenafine -- Intellectual property
Zileuton -- Intellectual property
Sibutramine -- Intellectual property
Death
Obesity
Vigabatrin
Tiagabine
Editors
Lamotrigine
Health
Subjects
Details
- Language :
- English
- ISSN :
- 15316386
- Database :
- Gale General OneFile
- Journal :
- Obesity, Fitness & Wellness Week
- Publication Type :
- Periodical
- Accession number :
- edsgcl.618876225